How do I choose a medical-grade antiaging treatment plan?
A real medical anti-ageing plan starts with measurements — blood pressure, cholesterol, blood sugar, organ function, a skin check, a review of what you already take — and treats what those show with drugs proven for it, monitored with repeat tests and a clear rule for stopping. Skin treatments and systemic treatments are separate plans. The off-label 'longevity' drugs, if used at all, come last and as experiments. A plan that skips the measurements, sells its own products or starts with the exotic items is a menu, not medicine.
A medical-grade anti-ageing plan is one built the way medicine is: measure first, treat what the measurements show with drugs proven for that finding, monitor, and stop what does not work. Ranked by how much each step separates a genuine plan from a clinic menu: first, a baseline — blood pressure, ApoB and lipoprotein(a), HbA1c, kidney, liver and thyroid function, a skin examination, a medication review — because a plan that treats before measuring is a sales process; second, treating the measured findings with on-label, outcome-proven drugs — antihypertensives, ApoB-lowering therapy, GLP-1 agonists where indicated, tretinoin for photodamage, HRT for symptoms in the window — before anything off-label; third, separating the skin plan from the systemic plan, because they have different evidence, different prescribers and different risks; fourth, monitoring with named tests at named intervals and a stated rule for stopping; fifth, pricing the plan by line so that the evidence-free items are visible; and sixth, treating off-label longevity drugs — rapamycin, metformin in non-diabetics, senolytics, hormone 'optimisation' — as experiments with consent, not as the plan. A plan that leads with the off-label items, sells its own products, skips the baseline or cannot name a stopping rule is not medical-grade whatever its letterhead says.
- Medical-grade means measured, indicated, monitored and reversible — not expensive, injectable or exclusive.
- The baseline is the step most often skipped, and skipping it is the surest sign of a menu rather than a plan.
- On-label, outcome-proven drugs for measured findings come first; they are also the cheapest and safest items on any plan.
- Skin and systemic anti-ageing are different disciplines with different evidence; a plan that blends them under one 'protocol' has usually diluted both.
- The off-label longevity drugs belong at the end, framed as experiments with informed consent, or not at all.
The steps, ranked by how much they separate a plan from a menu
Ranked on: how much each step distinguishes a medical-grade plan — measured, indicated, monitored, reversible — from a clinic menu, and how often skipping it is the mechanism by which people end up on drugs they do not need.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | 1. Baseline before anything is prescribed | The step that separates medicine from sales | GRADE AEstablished |
| 2 | 2. Treat the measured findings with on-label, outcome-proven drugs first | Where the evidence and the value both sit | GRADE AEstablished |
| 3 | 3. Separate the skin plan from the systemic plan | Different evidence, prescribers and risks | GRADE AEstablished |
| 4 | 4. Monitoring with named tests, intervals and a stopping rule | What makes it a plan rather than a purchase | GRADE AEstablished |
| 5 | 5. Price the plan by line | Makes the evidence-free items visible | GRADE BPromising |
| 6 | 6. Off-label longevity drugs last, as experiments with consent | Rapamycin, metformin, senolytics, hormone 'optimisation' | GRADE BPromising |
| 7 | 7. Compounded peptides, IV therapy, stem-cell and 'regenerative' offerings | The items whose presence disqualifies the plan | GRADE DInsufficient or unsafe |
- 01
1. Baseline before anything is prescribed
GRADE AEstablishedThe step that separates medicine from salesBlood pressure; ApoB and lipoprotein(a); HbA1c with fasting glucose and insulin; kidney, liver and thyroid function; ferritin and vitamin D; a skin examination with photographs; a full review of current medicines and supplements; and, where symptoms warrant, sex hormones. A plan that prescribes before measuring is treating a demographic, not a person.
- 02
2. Treat the measured findings with on-label, outcome-proven drugs first
GRADE AEstablishedWhere the evidence and the value both sitElevated blood pressure → antihypertensive to target; elevated ApoB → lipid-lowering therapy; obesity with cardiovascular disease or diabetes → GLP-1 agonist where indicated; photodamaged skin → tretinoin and sunscreen; menopausal symptoms within the window → HRT; diagnosed hypogonadism → testosterone with monitoring. Each has randomised outcome or appearance evidence for that finding. These are the anti-ageing drugs that work, and most are generic.
- 03
3. Separate the skin plan from the systemic plan
GRADE AEstablishedDifferent evidence, prescribers and risksVisible ageing is treated by dermatology with retinoids, depigmenting agents, neuromodulators and fillers, on trials measuring appearance. Systemic ageing risk is treated by internal medicine with cardiovascular and metabolic drugs, on trials measuring events. A 'longevity protocol' that blends both under one prescriber usually has weaker evidence and weaker monitoring for each.
- 04
4. Monitoring with named tests, intervals and a stopping rule
GRADE AEstablishedWhat makes it a plan rather than a purchaseEvery prescription carries a test that shows whether it is working and one that shows whether it is harming: lipids at three months for a statin; blood pressure at home; HbA1c at three to six months; photographs at six months for tretinoin; IGF-1 and glucose for any growth-hormone-axis agent; a full blood count and prostate assessment for testosterone. And a rule, written in advance, for what result stops the drug.
- 05
5. Price the plan by line
GRADE BPromisingMakes the evidence-free items visibleA plan priced as a package hides where the cost sits; priced by line, the generic on-label drugs cost little and the compounded, injectable and off-label items cost most — which is also, almost always, where the evidence is thinnest. Ask for the line prices and for what each line is expected to change.
- 06
6. Off-label longevity drugs last, as experiments with consent
GRADE BPromisingRapamycin, metformin, senolytics, hormone 'optimisation'None has human evidence for an ageing outcome; each has a known adverse-effect profile from its approved use. A medical-grade plan either omits them or includes them explicitly as n-of-1 experiments with written informed consent, a baseline, a monitoring schedule and a stopping rule — after steps one to four are in place, never instead of them.
- 07
7. Compounded peptides, IV therapy, stem-cell and 'regenerative' offerings
GRADE DInsufficient or unsafeThe items whose presence disqualifies the planMost compounded peptides have no lawful route from bulk in the US and no human trial; IV vitamin therapy has no outcome evidence; stem-cell and exosome offerings for ageing have an enforcement history. A plan that includes them is not medical-grade in the sense that matters, whatever else it contains.
Frequently asked questions
How do I choose a medical-grade anti-ageing treatment plan?
Ask for the sequence medicine uses: a baseline (blood pressure, ApoB and Lp(a), HbA1c, organ function, a skin exam, a medication review) before any prescription; on-label, outcome-proven drugs for the measured findings first; separate skin and systemic plans; monitoring with named tests, intervals and stopping rules; pricing by line; and off-label longevity drugs last, as consented experiments, or not at all. A plan that skips the baseline, leads with off-label items, sells its own products or includes compounded peptides and IVs is a menu.
What should be measured before an anti-ageing plan starts?
Blood pressure; ApoB and lipoprotein(a); HbA1c with fasting glucose and insulin; kidney, liver and thyroid function; ferritin and vitamin D; a skin examination with photographs; a full review of current medicines and supplements; and sex hormones where symptoms warrant. The findings, not the demographic, decide what is treated.
Which drugs should come first in a medical anti-ageing plan?
On-label drugs with outcome or appearance evidence for the measured finding: antihypertensives for raised blood pressure, lipid-lowering therapy for raised ApoB, a GLP-1 agonist where indicated, tretinoin and sunscreen for photodamage, hormone therapy for menopausal symptoms in the window, testosterone for diagnosed hypogonadism. They are the anti-ageing drugs that work, and most are generic.
Should rapamycin or metformin be part of a medical-grade plan?
If at all, last — as explicit experiments with written informed consent, a baseline, a monitoring schedule and a stopping rule, after the evidence-based items are in place. Neither has human evidence for an ageing outcome; both have known adverse-effect profiles from their approved uses. A plan that leads with them has its priorities inverted.
What makes a plan 'medical-grade'?
That it is measured, indicated, monitored and reversible: it treats findings rather than demographics, uses drugs with evidence for those findings, tests whether they are working and harming, and stops them when they are not. Price, injectables and exclusivity are not what makes a plan medical-grade; they are often what stops it being one.
What features mean a plan is not medical-grade?
No baseline before prescribing; off-label or compounded items as the first line; one 'protocol' blending skin and systemic treatment; retests that generate more product; package pricing that hides where the cost sits; products sold by the prescriber; and any compounded peptides, IV vitamin therapy or stem-cell offerings. Two or more of these and it is a menu.
Keep reading
- What are the most effective antiaging prescription treatments available?
The on-label drugs that belong at the front of the plan.
- How to choose the best longevity clinic package?
The unbundling method for the clinic version of the same decision.
- Which doctor-prescribed antiaging drugs are safest long term?
The long-term safety record behind each item.
- Free stack check
The medication review that belongs in the baseline.
More in Anti-aging pharma
- Rapamycin for longevity: what the human evidence actually shows
The only 48-week human trial (PEARL, n=129) missed its primary endpoint. What rapamycin has actually shown, the real risks, and who should never take it.
- What are the most effective antiaging prescription treatments available?
Anti-ageing prescription treatments ranked on randomised human evidence: tretinoin, botulinum toxin and fillers for visible ageing; GLP-1 agonists for metabolic ageing; statins and antihypertensives for the ageing that kills — and rapamycin, metformin, hormones and senolytics, which are prescribed for ageing without evidence for it.
- Which antiaging medicines deliver clinically proven wrinkle reduction results?
Medicines with clinically proven wrinkle reduction, ranked on randomised trials: botulinum toxin for dynamic lines, tretinoin and tazarotene for photoageing wrinkles, hyaluronic-acid fillers for folds, adapalene, then the over-the-counter retinol and peptides — and why sunscreen underwrites all of them.
- What antiaging pharmaceuticals work best for skin rejuvenation?
Anti-ageing pharmaceuticals for skin rejuvenation ranked on randomised evidence across texture, pigmentation, lines and volume: tretinoin, hydroquinone and tranexamic acid, botulinum toxin, fillers, azelaic acid, adapalene, oral isotretinoin (low-dose) — and the systemic drugs that do nothing for skin.
- Which doctor-prescribed antiaging drugs are safest long term?
Doctor-prescribed anti-ageing drugs ranked on long-term safety data: statins and antihypertensives (decades, millions), topical tretinoin, menopausal HRT in the window, GLP-1 agonists (years), metformin off-label, low-dose rapamycin, senolytics, testosterone 'optimisation' and growth hormone — with what is actually known about each over years.
- What antiaging medications should I discuss with my dermatologist?
The anti-ageing medications worth raising with a dermatologist, ranked by how much the prescription adds over what you can buy: tretinoin, hydroquinone and tranexamic acid, neuromodulators and fillers, tazarotene, azelaic acid, low-dose isotretinoin — and what to bring to the appointment.